Biomerica, Inc. (BMRA)

Revenue by Segment

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017	May 31, 2016
Development, Manufacture, Marketing, and Sale of Diagnostic Products	5.31M	5.42M	5.34M	18.87M	7.20M
Total	5.31M	5.42M	5.34M	18.87M	7.20M

Revenue by Geography

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017	May 31, 2016
Europe	1.30M	1.44M	1.80M	4.34M	4.30M
Asia	1.72M	1.88M	2.02M	13.38M	1.91M
North America	1.66M	1.29M	1.47M	997.00K	548.00K
Middle East	630.00K	800.00K	39.00K	70.00K	192.00K
South America	8.00K	11.00K	11.00K	90.00K	250.00K
Total	5.31M	5.42M	5.34M	18.87M	7.20M

Data Source: S&P Global Market Intelligence Last updated: Feb 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error